Meet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
Reliable clinical trial material (CTM) manufacturing built on process understanding, manufacturing flexibility, and cGMP quality systems.
Clinical manufacturing presents unique challenges. Processes continue to evolve, batch sizes change as programs progress, and manufacturing activities must support both immediate clinical supply needs and future development objectives.
We support the manufacture of clinical trial materials (CTM) across all phases of development, from early-phase studies through late-stage clinical programs. Our integrated development and manufacturing teams work together to maintain process knowledge as programs advance, helping ensure consistent product quality while accommodating changing timelines, volumes, and regulatory requirements.
As process understanding grows, manufacturing strategies evolve alongside the program. By combining manufacturing flexibility with established cGMP operations and scale-up expertise, we help customers generate the clinical supply needed today while building a stronger foundation for future validation and commercial manufacturing.
Clinical manufacturing plays an important role in establishing the foundation for future commercial success.
Through close alignment between development and manufacturing teams, we help build process knowledge, strengthen manufacturing controls, and generate the information needed to support technology transfer, process validation, and commercial manufacturing activities.
Whether you're preparing for early-phase clinical studies, Phase II scale-up, or late-stage clinical trial manufacturing, we can help define the right manufacturing strategy for your program.
Quick answers to help you better understand our CDMO capabilities and approach.
Still Have Questions? Contact UsClinical API manufacturing is the production of active pharmaceutical ingredients for use in clinical trials. It focuses on supplying clinical trial materials (CTM) while supporting ongoing process development, scale-up, and regulatory requirements.
CTM manufacturing refers to the production of clinical trial materials used in Phase I, Phase II, and Phase III studies. These materials must be manufactured under appropriate quality systems and in quantities that support clinical development objectives.
Clinical manufacturing supports investigational programs where processes may continue to evolve during development. Commercial manufacturing focuses on validated processes, larger production volumes, and long-term market supply following regulatory approval.
Yes. We support clinical trial material manufacturing across early-stage, mid-stage, and late-stage clinical programs, adapting manufacturing strategies to the evolving requirements of each phase.
Clinical development often generates new process knowledge and optimization opportunities. Our integrated development and manufacturing teams work together to evaluate and implement improvements while maintaining product quality, regulatory compliance, and supply continuity.
Clinical manufacturing helps build process understanding, establish manufacturing experience, and generate data that supports future scale-up, process validation, and commercial manufacturing activities.
Many companies engage a CDMO during process development or before First-in-Human studies to establish a scalable manufacturing strategy and ensure reliable CTM supply as the program advances through clinical development.
Yes. Well-executed clinical manufacturing activities help establish process knowledge and manufacturing experience that support future technology transfer, process validation, and commercial-scale production.
